GLP-1s tied to 37% higher hair loss risk, study finds
Mackenzie Bean / beckershospitalreview - GLP-1 receptor agonists carry a higher risk of hair loss than other diabetes medications, according to a study published July 22 in The BMJ. Researchers at Philadelphia-based Penn Medicine used EHR data to compare adults with Type 2 diabetes who started G…
AI Summary: A series of new analyses tie GLP‑1 diabetes and obesity drugs to a measurable rise in hair loss reports, with varying risk estimates prompting doctors to warn patients and researchers to dig deeper. Clinicians urge monitoring and clearer guidance as these widely used medications shift from metabolic miracles to potential cosmetic headaches.
OpenAI makes Health in ChatGPT widely available, moving deeper into consumer health
fiercehealthcare - OpenAI on Thursday made its Health in ChatGPT feature broadly available, enabling U.S. users to connect its artificial intelligence chatbot with medical records and wellness apps.
AI Summary: OpenAI has expanded the Health feature in ChatGPT to all US users, embedding symptom guidance, medication information and basic health tools into its consumer chat product. The rollout marks a deeper push into consumer health — offering easy access to medical-ish advice while predictably inviting scrutiny over safety, accuracy and data handling.
ChatGPT Health rollout and product details
Safety, liability and systemic concerns
Measles cases set 35-year US record with months to go in 2026
medicalxpress - The United States has recorded more measles cases this year than in any year since 1991, with more than five months still left on the calendar.
AI Summary: Measles has surged to levels not seen in decades, prompting clinicians to describe chaotic front-line care and mounting pediatric distress. Public-health officials and hospitals are managing outbreaks, vaccination gaps and increased hospitalizations, while providers urge broader immunization and rapid containment to blunt what is becoming a national public-health headache.